In this presentation, Dr. Stewart reviews current recommendations, clinical considerations, and supporting evidence for human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) and doxycycline post-exposure prophylaxis (DoxyPEP). Dr. Stewart also discusses… […]
Keyword: hiv
Test and Treat: HCV, HIV, Syphilis | July 16, 2026
In this presentation, faculty provide an overview of point-of-care testing for hepatitis C (HCV), HIV, and syphilis, including the types of tests currently available and their clinical applications. They examine… […]
Read More… from Test and Treat: HCV, HIV, Syphilis | July 16, 2026
Ending the Syndemic: A Tribal Health Approach | June 24, 2026
In this presentation, Dr. Jorge Mera, introduces the rationale, program design, leadership policies, and tools that may successfully be used by healthcare providers and tribal decision makers to develop and… […]
Read More… from Ending the Syndemic: A Tribal Health Approach | June 24, 2026
Providing PrEP and PEP Services at your Clinic | June 24, 2026
In this presentation, Bethany Johnson, PharmD, BCIDP, provides an overview of HIV prevention through pre-exposure prophylaxis (PrEP), nonoccupational post-exposure prophylaxis (nPEP), and doxycycline post-exposure prophylaxis (DoxyPEP), emphasizing evidence-based strategies to… […]
Read More… from Providing PrEP and PEP Services at your Clinic | June 24, 2026
Public Health Pharmacists Ending The Syndemic at Crow/Northern Cheyenne | May 20, 2026
In this presentation, Dr. Casey Marlin, and Marlaina Renney, summarize steps taken to establish an effective Patient Centered Medical Home clinic model, explain team member roles and workflow, and describe… […]
Maternal Child Syphilis | March 19, 2026
In this series of presentations, Dr. Jon Iralu, provides an overall infectious disease clinical update focusing on Mpox, gonorrhea, HIV, and syphilis. Then, Dr. James McAuley, MD, MPH, provides an… […]
Ending the Syndemic – Syphilis, HIV PrEP | March 10, 2026
In this presentation, Dr. Jorge Mera, explain the concept of a Syndemic, reviews the impact of the opioid epidemic in relation to the HIV & HCV epidemics and describes interventions… […]
Read More… from Ending the Syndemic – Syphilis, HIV PrEP | March 10, 2026
Ending the Syndemic in Indian Country | March 25, 2026
In this presentation, Dr. Jorge Mera, introduces the rationale, program design, leadership policies, and tools that may successfully be used by healthcare providers and tribal decision makers to develop and… […]
Read More… from Ending the Syndemic in Indian Country | March 25, 2026
Long-acting Injectable HIV PrEP | March 5, 2026
In this presentation, Dr. Gabrellas reviews the efficacy, safety, and dosing protocols of long-acting injectables (such as cabotegravir and lenacapavir) compared to daily oral PrEP, discusses monitoring plans and practical… […]
Read More… from Long-acting Injectable HIV PrEP | March 5, 2026
Long-acting Injectable HIV PrEP | March 4, 2026
In this presentation, Dr. Gabrellas reviews the efficacy, safety, and dosing protocols of long-acting injectables (such as cabotegravir and lenacapavir) compared to daily oral PrEP, discusses monitoring plans and practical… […]
Read More… from Long-acting Injectable HIV PrEP | March 4, 2026
